97 related articles for article (PubMed ID: 23111975)
1. Bioinformatics analysis of two microarray gene-expression data sets to select lung adenocarcinoma marker genes.
Wu X; Zang W; Cui S; Wang M
Eur Rev Med Pharmacol Sci; 2012 Oct; 16(11):1582-7. PubMed ID: 23111975
[TBL] [Abstract][Full Text] [Related]
2. A novel strategy of integrated microarray analysis identifies CENPA, CDK1 and CDC20 as a cluster of diagnostic biomarkers in lung adenocarcinoma.
Liu WT; Wang Y; Zhang J; Ye F; Huang XH; Li B; He QY
Cancer Lett; 2018 Jul; 425():43-53. PubMed ID: 29608985
[TBL] [Abstract][Full Text] [Related]
3. Identification of differential protein-coding gene expressions in early phase lung adenocarcinoma.
Zhou LN; Li SC; Li XY; Ge H; Li HM
Thorac Cancer; 2018 Feb; 9(2):234-240. PubMed ID: 29266838
[TBL] [Abstract][Full Text] [Related]
4. Reveals new lung adenocarcinoma cancer genes based on gene expression.
Lin ZF; Shen XY; Lu FZ; Ruan Z; Huang HL; Zhen J
Eur Rev Med Pharmacol Sci; 2012 Sep; 16(9):1249-56. PubMed ID: 23047510
[TBL] [Abstract][Full Text] [Related]
5. Construction of a 26‑feature gene support vector machine classifier for smoking and non‑smoking lung adenocarcinoma sample classification.
Yang L; Sun L; Wang W; Xu H; Li Y; Zhao JY; Liu DZ; Wang F; Zhang LY
Mol Med Rep; 2018 Feb; 17(2):3005-3013. PubMed ID: 29257283
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation mediated silencing of microRNA-145 is a potential prognostic marker in patients with lung adenocarcinoma.
Xia W; Chen Q; Wang J; Mao Q; Dong G; Shi R; Zheng Y; Xu L; Jiang F
Sci Rep; 2015 Nov; 5():16901. PubMed ID: 26582602
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of oncogenic protein kinase Ciota signaling in lung adenocarcinoma.
Erdogan E; Klee EW; Thompson EA; Fields AP
Clin Cancer Res; 2009 Mar; 15(5):1527-33. PubMed ID: 19223491
[TBL] [Abstract][Full Text] [Related]
8. Role of upregulated miR-136-5p in lung adenocarcinoma: A study of 1242 samples utilizing bioinformatics analysis.
Li TT; Gao X; Gao L; Gan BL; Xie ZC; Zeng JJ; Chen G
Pathol Res Pract; 2018 May; 214(5):750-766. PubMed ID: 29526559
[TBL] [Abstract][Full Text] [Related]
9. MAGE-A family expression is correlated with poor survival of patients with lung adenocarcinoma: a retrospective clinical study based on tissue microarray.
Sang M; Gu L; Yin D; Liu F; Lian Y; Zhang X; Liu S; Huang W; Wu Y; Shan B
J Clin Pathol; 2017 Jun; 70(6):533-540. PubMed ID: 27864450
[TBL] [Abstract][Full Text] [Related]
10. Identification of stage-specific biomarkers in lung adenocarcinoma based on RNA-seq data.
Liang J; Lv J; Liu Z
Tumour Biol; 2015 Aug; 36(8):6391-9. PubMed ID: 25861020
[TBL] [Abstract][Full Text] [Related]
11. Joint analysis of two microarray gene-expression data sets to select lung adenocarcinoma marker genes.
Jiang H; Deng Y; Chen HS; Tao L; Sha Q; Chen J; Tsai CJ; Zhang S
BMC Bioinformatics; 2004 Jun; 5():81. PubMed ID: 15217521
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics approach reveals systematic mechanism underlying lung adenocarcinoma.
Wu X; Zhang W; Hu Y; Yi X
Tumori; 2015; 101(3):281-6. PubMed ID: 26045113
[TBL] [Abstract][Full Text] [Related]
13. Blocking transferrin receptor inhibits the growth of lung adenocarcinoma cells in vitro.
Wu Y; Xu J; Chen J; Zou M; Rusidanmu A; Yang R
Thorac Cancer; 2018 Feb; 9(2):253-261. PubMed ID: 29286585
[TBL] [Abstract][Full Text] [Related]
14. WDR62 overexpression is associated with a poor prognosis in patients with lung adenocarcinoma.
Shinmura K; Kato H; Kawanishi Y; Igarashi H; Inoue Y; Yoshimura K; Nakamura S; Fujita H; Funai K; Tanahashi M; Niwa H; Ogawa H; Sugimura H
Mol Carcinog; 2017 Aug; 56(8):1984-1991. PubMed ID: 28277612
[TBL] [Abstract][Full Text] [Related]
15. Clinical value of miR-452-5p expression in lung adenocarcinoma: A retrospective quantitative real-time polymerase chain reaction study and verification based on The Cancer Genome Atlas and Gene Expression Omnibus databases.
Gan XN; Luo J; Tang RX; Wang HL; Zhou H; Qin H; Gan TQ; Chen G
Tumour Biol; 2017 May; 39(5):1010428317705755. PubMed ID: 28488527
[TBL] [Abstract][Full Text] [Related]
16. [Omics technologies in diagnostics of lung adenocarcinoma].
Novikova SE; Kurbatov LK; Zavialova MG; Zgoda VG; Archakov AI
Biomed Khim; 2017 May; 63(3):181-210. PubMed ID: 28781253
[TBL] [Abstract][Full Text] [Related]
17. miR-126-3p and miR-451a correlate with clinicopathological features of lung adenocarcinoma: The underlying molecular mechanisms.
Chen Q; Hu H; Jiao D; Yan J; Xu W; Tang X; Chen J; Wang J
Oncol Rep; 2016 Aug; 36(2):909-17. PubMed ID: 27277197
[TBL] [Abstract][Full Text] [Related]
18. Role for High-Affinity IgE Receptor in Prognosis of Lung Adenocarcinoma Patients.
Ly D; Zhu CQ; Cabanero M; Tsao MS; Zhang L
Cancer Immunol Res; 2017 Sep; 5(9):821-829. PubMed ID: 28775209
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic role of miR‑183‑5p in lung adenocarcinoma: A comprehensive study of qPCR, in vitro experiments and bioinformatic analysis.
He RQ; Gao L; Ma J; Li ZY; Hu XH; Chen G
Oncol Rep; 2018 Jul; 40(1):83-100. PubMed ID: 29749535
[TBL] [Abstract][Full Text] [Related]
20. Gene expression analysis of lung adenocarcinoma and matched adjacent non-tumor lung tissue.
Zhang W; Gong W; Ai H; Tang J; Shen C
Tumori; 2014; 100(3):338-45. PubMed ID: 25076248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
